Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?

被引：0
|
作者：
Paula, Arnaud Da Cruz [1 ]
Smith, Evan [1 ]
Cadoo, Karen [1 ]
Abu-Rustum, Nadeem [1 ]
Pei, Xin [1 ]
Riaz, Nadeem [1 ]
Robson, Mark [1 ]
Reis-Filho, Jorge [1 ]
Mandelker, Diana [1 ]
Weigelt, Britta [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1020
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [2] Endometrial cancers in BRCA1 or BRCA2 germline mutations carriers
    Smith, E.
    Paula, A. D. C.
    Cadoo, K. A.
    Abu-Rustum, N. R.
    Pei, X.
    Riaz, N.
    Robson, M. E.
    Reis-Filho, J.
    Mandelker, D.
    Weigelt, B.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 65 - 65
  • [3] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    [J]. CANCER RESEARCH, 2016, 76
  • [4] Pathology of ovarian cancers in BRCA1 and BRCA2 carriers
    Lakhani, SR
    Manek, S
    Penault-Llorca, F
    Flanagan, A
    Arnout, L
    Merrett, S
    McGuffog, L
    Steele, D
    Devilee, P
    Klijn, JGM
    Meijers-Heijboer, H
    Radice, P
    Pilotti, S
    Nevanlinna, H
    Butzow, R
    Sobol, H
    Jacquemier, J
    Lyonet, DS
    Neuhausen, SL
    Weber, B
    Wagner, T
    Winqvist, R
    Bignon, YJ
    Monti, F
    Schmitt, F
    Lenoir, G
    Seitz, S
    Hamman, U
    Pharoah, P
    Lane, G
    Ponder, B
    Bishop, DT
    Easton, DF
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2473 - 2481
  • [5] An immunohistochemical comparison of ovarian cancers tested for germline BRCA1/BRCA2 mutations
    Djordjevic, B
    Tone, A
    Begley, H
    Murphy, J
    Rosen, B
    McLaughlin, J
    Narod, S
    Shaw, PA
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 176A - 176A
  • [6] An immunohistochemical comparison of ovarian cancers tested for germline BRCA1/BRCA2 mutations
    Djordjevic, B
    Tone, A
    Begley, H
    Murphy, J
    Rosen, B
    McLaughlin, J
    Narod, S
    Shaw, PA
    [J]. MODERN PATHOLOGY, 2006, 19 : 176A - 176A
  • [7] Immunophenotypic characterization of breast cancers in carriers of BRCA1/BRCA2 mutations.
    Simon, SD
    Bacchi, CE
    Molina, AL
    Moreira-Filho, CA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 870S - 870S
  • [8] A family with three germline mutations in BRCA1 and BRCA2
    Liede, A
    Metcalfe, K
    Offit, K
    Brown, K
    Miller, S
    Narod, SA
    Moslehi, R
    [J]. CLINICAL GENETICS, 1998, 54 (03) : 215 - 218
  • [9] BRCA1 and BRCA2 germline mutations in lymphoma patients
    Yossepowitch, O
    Olvera, N
    Satagopan, JM
    Huang, H
    Jhanwar, S
    Rapaport, B
    Boyd, J
    Offit, K
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (01) : 127 - 131
  • [10] Surveillance of BRCA1 and BRCA2 carriers
    Helvie, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08): : 931 - 931
12345